Matches in SemOpenAlex for { <https://semopenalex.org/work/W2908082134> ?p ?o ?g. }
- W2908082134 endingPage "31" @default.
- W2908082134 startingPage "22" @default.
- W2908082134 abstract "Leucurogin is an ECD disintegrin-like protein, cloned from Bothrops leucurus venom gland. This new protein, encompassing the disintegrin region of a PIII metalloproteinase, is produced by recombinant technology and its biological and functional activity was partially characterized in this study. Biological activity was characterized in vitro using human fibroblasts. Functional activity of leucurogin was analysed in vitro and in vivo with murine B16F10 Nex-2 and human melanoma BLM cells. The results show that leucurogin inhibits cellular processes dependent on collagen type I. In a competition assay with collagen, leucurogin inhibits, in a dose-dependent manner, the adhesion of fibroblast to collagen. At 10 μM leucurogin reduces adhesion (40%) and migration (70%) of hFb and inhibits migration (32%) and proliferation (65%) of BLM cells. At 2.5 μM leucurogin inhibits 80% cell proliferation of B16F10 Nex-2 melanoma cells. At 4.8 μM leucurogin inhibits, in vitro, the vascular structures formation by endothelial cells by 66%. Leucurogin, injected intraperitoneally, i.p. (5 μg/animal, two-month old C57/Bl6 male mice) on alternate days for 15 days, inhibits lung metastasis of B16F10 Nex-2 cells by 70–75%. In the treatment of human melanoma, grafted intradermally in the nude mice flank, leucurogin (7.5 μg/kg in alternate days during 17 days) inhibits tumor growth by more than 40%. Leucurogin can be considered a promising agent for melanoma treatment." @default.
- W2908082134 created "2019-01-11" @default.
- W2908082134 creator A5033536531 @default.
- W2908082134 creator A5038260780 @default.
- W2908082134 creator A5039615890 @default.
- W2908082134 creator A5046860030 @default.
- W2908082134 creator A5061611407 @default.
- W2908082134 creator A5064446187 @default.
- W2908082134 creator A5074953319 @default.
- W2908082134 creator A5077309954 @default.
- W2908082134 creator A5079282067 @default.
- W2908082134 date "2019-03-01" @default.
- W2908082134 modified "2023-10-01" @default.
- W2908082134 title "Leucurogin and melanoma therapy" @default.
- W2908082134 cites W1532085934 @default.
- W2908082134 cites W1565563859 @default.
- W2908082134 cites W1651215666 @default.
- W2908082134 cites W1935244633 @default.
- W2908082134 cites W1964433907 @default.
- W2908082134 cites W1967080411 @default.
- W2908082134 cites W1967868924 @default.
- W2908082134 cites W1968654211 @default.
- W2908082134 cites W1969392115 @default.
- W2908082134 cites W1973814270 @default.
- W2908082134 cites W1978041336 @default.
- W2908082134 cites W1978160288 @default.
- W2908082134 cites W1981920010 @default.
- W2908082134 cites W1987209094 @default.
- W2908082134 cites W1992885568 @default.
- W2908082134 cites W1994374087 @default.
- W2908082134 cites W1996780355 @default.
- W2908082134 cites W2004346157 @default.
- W2908082134 cites W2008732608 @default.
- W2908082134 cites W2009821528 @default.
- W2908082134 cites W2010828282 @default.
- W2908082134 cites W2013789509 @default.
- W2908082134 cites W2015651255 @default.
- W2908082134 cites W2022574738 @default.
- W2908082134 cites W2029231027 @default.
- W2908082134 cites W2029763637 @default.
- W2908082134 cites W2033791403 @default.
- W2908082134 cites W2034291695 @default.
- W2908082134 cites W2034956882 @default.
- W2908082134 cites W2034992352 @default.
- W2908082134 cites W2035743945 @default.
- W2908082134 cites W2036697376 @default.
- W2908082134 cites W2040799583 @default.
- W2908082134 cites W2043383369 @default.
- W2908082134 cites W2053235962 @default.
- W2908082134 cites W2055516201 @default.
- W2908082134 cites W2055785948 @default.
- W2908082134 cites W2060341044 @default.
- W2908082134 cites W2063220206 @default.
- W2908082134 cites W2071062791 @default.
- W2908082134 cites W2076511007 @default.
- W2908082134 cites W2080135127 @default.
- W2908082134 cites W2089937475 @default.
- W2908082134 cites W2091904850 @default.
- W2908082134 cites W2097309924 @default.
- W2908082134 cites W2100363932 @default.
- W2908082134 cites W2106929134 @default.
- W2908082134 cites W2111897596 @default.
- W2908082134 cites W2120209561 @default.
- W2908082134 cites W2120287343 @default.
- W2908082134 cites W2126575512 @default.
- W2908082134 cites W2136731274 @default.
- W2908082134 cites W2142985700 @default.
- W2908082134 cites W2146307140 @default.
- W2908082134 cites W2146955304 @default.
- W2908082134 cites W2147000598 @default.
- W2908082134 cites W2159559365 @default.
- W2908082134 cites W2160042168 @default.
- W2908082134 cites W2172167342 @default.
- W2908082134 cites W2186848496 @default.
- W2908082134 cites W2273655965 @default.
- W2908082134 cites W2340708452 @default.
- W2908082134 cites W2520376235 @default.
- W2908082134 cites W2610738432 @default.
- W2908082134 cites W2885531730 @default.
- W2908082134 cites W2889304659 @default.
- W2908082134 cites W347737989 @default.
- W2908082134 cites W4213141530 @default.
- W2908082134 cites W4293247451 @default.
- W2908082134 cites W4322717319 @default.
- W2908082134 doi "https://doi.org/10.1016/j.toxicon.2018.12.005" @default.
- W2908082134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30611825" @default.
- W2908082134 hasPublicationYear "2019" @default.
- W2908082134 type Work @default.
- W2908082134 sameAs 2908082134 @default.
- W2908082134 citedByCount "4" @default.
- W2908082134 countsByYear W29080821342020 @default.
- W2908082134 countsByYear W29080821342023 @default.
- W2908082134 crossrefType "journal-article" @default.
- W2908082134 hasAuthorship W2908082134A5033536531 @default.
- W2908082134 hasAuthorship W2908082134A5038260780 @default.
- W2908082134 hasAuthorship W2908082134A5039615890 @default.
- W2908082134 hasAuthorship W2908082134A5046860030 @default.
- W2908082134 hasAuthorship W2908082134A5061611407 @default.